JPH0457641B2 - - Google Patents
Info
- Publication number
- JPH0457641B2 JPH0457641B2 JP59019249A JP1924984A JPH0457641B2 JP H0457641 B2 JPH0457641 B2 JP H0457641B2 JP 59019249 A JP59019249 A JP 59019249A JP 1924984 A JP1924984 A JP 1924984A JP H0457641 B2 JPH0457641 B2 JP H0457641B2
- Authority
- JP
- Japan
- Prior art keywords
- water
- skin
- lipid mixture
- moisture
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は、皮膚表面の水分を保ち、常に皮膚に
潤いを与える保水機能の優れた皮膚外用剤特に化
粧料に関するものである。更に詳しく述べるなら
ば、本発明は牛、馬等の哺乳動物の脳組織より得
られた保水機能を有する脂質混合物を有効成分と
して水を含有する外用基剤中に配合することによ
り、ひび、あかぎれ等の主に皮膚の乾燥に起因し
悪化する疾患に対し有用な効果を発揮する皮膚外
用剤や皮膚の老化防止、潤い、なめらかさなどの
感触及び皮膚外観の美した等を付与する化粧料を
提供せんとするものである。
従来、一般的にひび、あかぎれ等に冬期に空気
が乾燥した時、皮膚の分泌物特に脂質の減退によ
りバリヤー機能が減少し、保水成分による水分貯
留能力を超えて経表皮性水分損失(以下T.W.L
と略)が大きくなつたり、または物理的原因(例
えば洗浄等)により、表皮内(特に角質層)水分
が引き出された結果、誘発される症状である。一
方、魚鱗癬と呼ばれる角化症の1種は、皮膚が荒
れて乾燥し、表面がひび割れ状をなし、鱗状に見
える症状で、これは冬期乾燥時に特に悪化すると
言われる。また、通常時においても年令や体質に
より角質層水分含有量が10%程度になつた状態を
ドライスキンと呼び、老人性乾皮症などが好適な
例として挙げられる。以上、これらは表皮角質層
の水分が、通常は角質層の構成成分と結合し皮膚
機能を正常に維持してているが、環境変化(低温
度、低湿度下)や老化等によつて角質層の水分含
有量が減少すると、皮膚がカサカサになつたり脆
くなつてひび割れたりする肌あれを生ずることと
密接な関連を持つているものである。そして、こ
れらの症状に対処する為には、角質層水分含有量
の低下を防止し、皮膚機能を正常に維持すること
が必要であり、各種の方法が研究されてきた。
従来、行われてきたこのような方法としては、
閉塞剤を用いてT.W.Lを抑制する方法と保湿剤
を用いて皮膚水和効果を高める方法とがあつた。
前者の例としては、ワセリン軟膏が良く知ら
れ、また特開昭54−86630号に見られる如く、皮
脂類似組成物を配合し、皮膚表面を被い乾燥を防
止する方法などがあつたが、これらの場合、効果
を高めるためには使用量(塗布量)を多くしなけ
ればならず、そのことにより使用中油つぽく、ベ
タベタする等の不快な感触になり、また逆に使用
量が少ないと閉塞性が弱く持続性がないと言う欠
点があつた。
一方、後者の例としては、エチレングリコー
ル、プロピレングリコール、1.3−ブチレングリ
コール、グリセリン等の多価アルコールやPCA
−ソーダ等の保湿剤が用いられるが、これらは水
との相溶性は良いがそれ自身保水能力は余り高く
なく、また低湿度下では皮膚の水分を保持するど
ころか逆に保湿剤が皮膚から水分を吸い上げてし
まい(特にグリセリンでは顕著)、高湿度下では
外気中の水分を吸つてベタベタした不快感を与
え、逆に使用量を抑えるとその効果は弱く持続性
がないという致命的な欠陥があつた。
そこで、本発明者らは、これら前述の従来法に
おける欠点を解決し、水分保持機能の高い物質な
らびに剤型を見い出すべく鋭意研究したところ、
哺乳動物の脳組織より得られた脂質混合物を外用
基剤や化粧料基剤中に配合したた場合に、皮膚上
で水を含んだ液晶状態を形成し、閉塞性、保水性
に優れたものが得られることを突止め、本発明の
完成に至つた。
すなわち、本発明は哺乳動物の脳組織を用い、
これを水とは任意の割合では混和しない極性の低
い有機溶媒で、あるいは該有機溶媒と低級アルキ
ルアルコールとの混合物で抽出して得られたリン
脂質、糖脂質、コレステロールを主成分とする脂
質混合物を有効成分として水を含有する外用基剤
中に配合することを特徴とする皮膚外用剤に関す
るものである。
本発明に適用される脂質混合物は、哺乳動物例
えば牛、馬、豚、猿、犬等の動物の脳組織より得
られるものである。また、これら動物脳組織を用
いて本発明に係る脂質混合物を得るには、以下に
示すような方法が採用される。すなわち、まず新
鮮な脳組織を用い、前処理として摩砕機により摩
砕したものを凍結乾燥するか、または水と任意の
割合で混和し得る有機溶媒例えばメタノール、エ
タノール、アセトン、THF等とともにホモゲネ
ートするかして、脳組織中の水分を脱水する。こ
の脱水処理は、以降の抽出操作における抽出溶媒
量を減らすとともに、抽出効率をも高める為に実
施するものである。
次に、脱水処理された脳組織に有機溶媒を加え
て充分に抽出する。ここで使用される有機溶媒と
しては極性の低いもの、言い換えると水とは任意
の割合では混和し得ないのが好ましく、具体的に
はn−ヘキサン、n−ヘプタン、石油エーテル、
エチルエーテル、クロロホルムなどの単独乃至は
混合溶媒が例示され、あるいは上記有機溶媒と低
級アルキルアルコールとの混和物、具体的にはn
−ヘキサン/エタノール、エチルエーテル/エタ
ノール、クロロホルム/メタノールなどの混合溶
媒が例示される。そして更に抽出液は、水もしく
はKcl、Cacl2等の塩水溶液で洗浄された後、溶
媒を留去して目的の脂質混合物を得るものであ
る。
斯様にして得られた上記の脂質混合物は、一般
的には淡黄色乃至は黄色のロウ状乃至は固体状の
物質で、粗成的にはホスフアチジルコリン、ホス
フアチジルエタノールアミン等のグリセロリン脂
質(脂質混合物中の30〜45%、以下、同様とす
る)、スフインゴミエリン等のスフインゴリン脂
質(5〜15%)、セレブロシド等のスフインゴ糖
脂質(10〜30%)、コレステロール(20〜35%)
などを主成分とし、その他セラミド、多糖類、蛋
白類、塩類などを微量含有する複雑な混合物とな
つている。
以下、さらに本発明に係る脂質混合物について
詳細に説明するために、その製造例を示す。
製造例 1
新鮮な牛脳100gを15gの95%エタノールとホ
モゲナイズした後、95%エタノール250mlを加え
て混合攪拌した。これをロ過して抽出液と残渣を
分離した後、残渣にn−ヘキサン300mlを加えて
混合攪拌し充分に抽出した。これをロ過して得ら
れた抽出液を0.75%Kcl水溶液60mlで水洗した。
この操作を2回繰り返した後、抽出液を減圧下、
40℃以下で有機溶媒を留去して淡黄色固体の牛脳
脂質9.6gを得た。
製造例 2
新鮮な豚脳100gを摩砕機で摩砕した後、凍結
乾燥を行なつた。次に、これにクロロホルム−メ
タノール(2:1V/V)混合溶媒500mlを加えて
混合攪拌し充分に抽出した。これをロ過して得ら
れた抽出液を、0.04%Cacl2水溶液80mlで水洗し
た。そして抽出液は減圧下、40℃以下で有機溶媒
を留去して淡黄色ロウ状の豚脳脂質8.9gを得た。
次に、本発明における前記脂質混合物の配合量
は、適用される皮膚外用剤または化粧料の剤型に
応じて幅広く変動し得るのの、概ね0.05〜90重量
%、好ましくは0.05〜20重量%の範囲である。即
ち、脂質混合物は水との混合系において水を取り
込んだ形での液晶形成能が高く、従つて塗布後の
皮膚上での保水能も大きいが、多量に配合した場
合には、油つぽく、ベタつき感を生じ化粧料とし
ては好ましくないこともある。
一方、本発明で使用れる水以外の他の原料成分
としては、通常皮膚外用剤や化粧料に適用される
油脂類、界面活性剤、多価アルコール類を含む保
湿剤、各種薬効成分、防腐剤などほとんどの成分
が挙げられ、その中から目的、用途、剤型等に応
じて適宜選択され調整される。しかし、ここで重
要な点は、皮膚への製品塗布後に液晶形成を阻害
しない処方系とすることが肝要であり、このた
め、例えば油脂類については、ミリスチン酸、パ
ルミチン酸、ステアリン酸、セタノール、ステア
リルアルコール、ミツロウ、マイクロクリスタリ
ンワツクス等に代表される固体脂と流動パラフイ
ン、スクワラン、大豆油、オリーブ油、ミリスチ
ン酸オクチルドデシル等に代表される液体脂とを
較べた場合、特に液体脂が好ましく、また液体脂
と固体脂を組合せて配合する場合には液体脂リツ
チとするのがより効果的である。一方、多価アル
コールについても、エチレングリコール、プロピ
レングリコール、1.3−ブチレングリコール、グ
リセリン、ジグリセリン、ポリエチレングリコー
ル、ポリグリセリンなどが挙げられるが、やはり
液晶形成の点を勘案すると、特にグリセリンもし
くはグリセリンと他の多価アルコールとの混合物
の場合がより好ましい。
以上のように脂質混合物、油脂類、多価アルコ
ール、及び水等により構成された皮膚外用剤や化
粧料の場合には、処方系中で、乃至は皮膚に塗布
したのち揮発性物質(特に水)の蒸散に伴ない脂
質混合物含有比率が、残存物全重量に対して0.5
〜20重量%好ましくは1〜5重量%の範囲に達し
た時点で、水を取り込んだ状態の液晶を形成し、
最も保水、閉塞効果の優れたものとなる。
ここで、本発明に係る脂質混合物が水を取り込
んだ状態での液晶形成能が高く、保水能に如何に
優れているかを評価した結果を示す。
1 吸湿性評価
Γ 試料:製造例1で得られた本発明に係る牛脳
抽出脂質混合物と比較品としてグリセリン及び
プロピレングリコールを用いた。
Γ 方法:上記の試料をそれぞれ5gずつ、直径
3cmのシヤーレに秤り取り、これを相対湿度
RH=98%に調整したデシケーダ中にセツト
し、24時間後、48時間後の試料重量を測定して
吸湿率*1)を算出した。その結果を表−1に示
す。
*1)
吸湿率=経時後試料重量(g)/
5(g)×100
TECHNICAL FIELD The present invention relates to an external skin preparation, particularly a cosmetic, which retains moisture on the skin surface and has an excellent water-retaining function that constantly moisturizes the skin. More specifically, the present invention cures cracks and chaps by incorporating a lipid mixture with a water-retaining function obtained from the brain tissue of mammals such as cows and horses into a water-containing external base as an active ingredient. External skin preparations that have a useful effect on diseases that worsen mainly due to skin dryness, and cosmetics that prevent skin aging and provide moisture, smoothness, and a beautiful skin appearance. This is what we intend to provide. Conventionally, when the air is dry in winter, typically due to cracks and chapped skin, the barrier function decreases due to a decrease in skin secretions, especially lipids, and the water retention capacity of the water-retaining components is exceeded, resulting in transepidermal water loss (hereinafter referred to as TWL).
This is a symptom that is induced as a result of the moisture in the epidermis (especially the stratum corneum) being drawn out due to an increase in the size of the epidermis (abbreviation) or due to physical causes (such as washing). On the other hand, a type of keratosis called ichthyosis is a condition in which the skin becomes rough and dry, with a cracked and scaly appearance on the surface, and this condition is said to be especially worse during dry winter months. Furthermore, a condition in which the moisture content of the stratum corneum is about 10% even under normal conditions depending on age and constitution is called dry skin, and senile xeroderma is a suitable example. As mentioned above, the moisture in the stratum corneum of the epidermis normally combines with the constituent components of the stratum corneum to maintain normal skin functions, but due to environmental changes (low temperature, low humidity), aging, etc. A decrease in the moisture content of the layer is closely associated with the appearance of rough skin, where the skin becomes dry, brittle, and cracked. In order to deal with these symptoms, it is necessary to prevent a decrease in the water content of the stratum corneum and maintain normal skin function, and various methods have been studied. Conventionally, this method is as follows:
There are two methods: using an occlusive agent to suppress TWL and using a humectant to enhance skin hydration. As an example of the former, Vaseline ointment is well known, and as seen in JP-A-54-86630, there is a method in which a sebum-like composition is blended and the skin surface is coated to prevent dryness. In these cases, in order to increase the effect, it is necessary to use a large amount (amount of application), which results in an unpleasant feeling such as oiliness and stickiness during use, and conversely, if the amount used is small, It had the disadvantage of weak occlusion and lack of durability. On the other hand, examples of the latter include polyhydric alcohols such as ethylene glycol, propylene glycol, 1.3-butylene glycol, glycerin, and PCA.
- Moisturizers such as soda are used, but although these have good compatibility with water, their own water retention capacity is not very high, and in low humidity conditions, rather than retaining moisture in the skin, the moisturizer may actually remove moisture from the skin. (especially noticeable with glycerin), and under high humidity conditions, it absorbs moisture from the outside air, causing a sticky and unpleasant feeling.On the other hand, if you reduce the amount used, the effect is weak and does not last long, which is a fatal flaw. It was hot. Therefore, the present inventors conducted intensive research in order to solve the drawbacks of the above-mentioned conventional methods and find a substance and dosage form with a high moisture retention function.
When a lipid mixture obtained from mammalian brain tissue is blended into a topical base or cosmetic base, it forms a water-containing liquid crystal state on the skin and has excellent occlusive properties and water retention properties. It was discovered that the following could be obtained, leading to the completion of the present invention. That is, the present invention uses mammalian brain tissue,
A lipid mixture containing phospholipids, glycolipids, and cholesterol as main components obtained by extracting this with a low polar organic solvent that is immiscible with water in any proportion, or with a mixture of the organic solvent and lower alkyl alcohol. The present invention relates to a skin preparation for external use, which is characterized in that it is blended into an external use base containing water as an active ingredient. The lipid mixture applied to the present invention is obtained from the brain tissue of mammals such as cows, horses, pigs, monkeys, and dogs. Further, in order to obtain the lipid mixture according to the present invention using these animal brain tissues, the following method is adopted. That is, first, fresh brain tissue is used, and as a pretreatment, it is ground with a grinder and freeze-dried, or it is homogenized with an organic solvent that is miscible with water in any proportion, such as methanol, ethanol, acetone, THF, etc. This dehydrates the water in the brain tissue. This dehydration treatment is carried out in order to reduce the amount of extraction solvent used in subsequent extraction operations and to also increase extraction efficiency. Next, an organic solvent is added to the dehydrated brain tissue to thoroughly extract it. The organic solvent used here is preferably one with low polarity, in other words, it is immiscible with water in any proportion; specifically, n-hexane, n-heptane, petroleum ether,
Examples include single or mixed solvents such as ethyl ether and chloroform, or mixtures of the above organic solvents and lower alkyl alcohols, specifically n
- Mixed solvents such as hexane/ethanol, ethyl ether/ethanol, and chloroform/methanol are exemplified. The extract is further washed with water or an aqueous salt solution such as Kcl, Cacl 2, etc., and then the solvent is distilled off to obtain the desired lipid mixture. The above-mentioned lipid mixture obtained in this manner is generally a pale yellow to yellow waxy or solid substance, and crudely contains phosphatidylcholine, phosphatidylethanolamine, etc. Glycerophospholipids (30-45% of the lipid mixture, hereinafter the same), sphingophospholipids such as sphingomyelin (5-15%), sphingoglycolipids such as cerebroside (10-30%), cholesterol (20-30%) 35%)
It is a complex mixture containing trace amounts of ceramides, polysaccharides, proteins, salts, etc. as its main components. Hereinafter, in order to further explain the lipid mixture according to the present invention in detail, a production example thereof will be shown. Production Example 1 After 100 g of fresh bovine brain was homogenized with 15 g of 95% ethanol, 250 ml of 95% ethanol was added and mixed and stirred. After this was filtered to separate the extract and the residue, 300 ml of n-hexane was added to the residue and mixed and stirred for thorough extraction. The extract obtained by filtration was washed with 60 ml of 0.75% KCl aqueous solution.
After repeating this operation twice, the extract was extracted under reduced pressure.
The organic solvent was distilled off at below 40°C to obtain 9.6 g of bovine brain lipid as a pale yellow solid. Production Example 2 After grinding 100 g of fresh pig brain using a grinder, it was freeze-dried. Next, 500 ml of a mixed solvent of chloroform-methanol (2:1 V/V) was added to this, and the mixture was mixed and stirred for thorough extraction. The extract obtained by filtration was washed with 80 ml of 0.04% CaCl 2 aqueous solution. Then, the organic solvent was distilled off from the extract under reduced pressure at 40° C. or lower to obtain 8.9 g of pale yellow waxy pig brain lipid. Next, the amount of the lipid mixture in the present invention can vary widely depending on the dosage form of the applied skin preparation or cosmetic, but is approximately 0.05 to 90% by weight, preferably 0.05 to 20% by weight. is within the range of In other words, lipid mixtures have a high ability to form liquid crystals when mixed with water, and therefore have a high ability to retain water on the skin after application, but when mixed in large amounts, they tend to become oily. , it may give a sticky feeling and may be undesirable as a cosmetic. On the other hand, raw materials other than water used in the present invention include oils and fats, surfactants, humectants containing polyhydric alcohols, various medicinal ingredients, and preservatives that are usually applied to external skin preparations and cosmetics. Most of the ingredients are listed, and are appropriately selected and adjusted depending on the purpose, use, dosage form, etc. However, the important point here is that the formulation system does not inhibit liquid crystal formation after application of the product to the skin.For this reason, for example, regarding oils and fats, myristic acid, palmitic acid, stearic acid, cetanol, When comparing solid fats represented by stearyl alcohol, beeswax, microcrystalline wax, etc. and liquid fats represented by liquid paraffin, squalane, soybean oil, olive oil, octyldodecyl myristate, etc., liquid fats are particularly preferred. Furthermore, when blending a combination of liquid fat and solid fat, it is more effective to make the mixture rich in liquid fat. On the other hand, examples of polyhydric alcohols include ethylene glycol, propylene glycol, 1.3-butylene glycol, glycerin, diglycerin, polyethylene glycol, and polyglycerin. More preferred is a mixture with a polyhydric alcohol. As mentioned above, in the case of external skin preparations and cosmetics composed of lipid mixtures, oils and fats, polyhydric alcohols, water, etc., volatile substances (particularly water, etc.) are ) due to transpiration, the lipid mixture content ratio is 0.5 to the total weight of the residue.
~20% by weight, preferably in the range of 1 to 5% by weight, forming a liquid crystal that incorporates water,
It has the best water retention and occlusion effect. Here, the results of evaluating how the lipid mixture according to the present invention has a high liquid crystal forming ability in a state in which water is incorporated and how excellent it is in water retention ability are shown. 1 Hygroscopicity Evaluation Γ Sample: The bovine brain extract lipid mixture according to the present invention obtained in Production Example 1 and glycerin and propylene glycol were used as comparison products. Γ Method: Weigh 5g of each of the above samples into a 3cm diameter shear dish, and add it to the relative humidity.
The sample was placed in a desicada adjusted to RH = 98%, and the weight of the sample was measured after 24 and 48 hours to calculate the moisture absorption rate *1) . The results are shown in Table-1. *1) Moisture absorption rate = Sample weight after aging (g) / 5 (g) x 100
【表】
2 水分保持能評価
Γ 試料:(イ)製造例1で得られた本発明に係る牛
脂抽出脂質混合物と、比較品として(ロ)スフイン
ゴミエリン(リン脂質)、(ハ)セレブロシド(糖
脂質)、(ニ)コレステロール、(ホ)スフインゴミエ
リンとセレブロシドとの等量混合物、(ヘ)スフイ
ンゴミエリンとコレステロールの等量混合物、
(ト)セレブロシドとコレステロールの等量混合物
とを用いた。
Γ 方法:(イ)〜(ト)の試料に対してそれぞれ4重量
倍量の水を加えて膨潤させたもの(80重量%含
水物)をそれぞれ1gづつ、直径3cmのシヤー
レに秤り取り、これを温度5℃、RH45%のフ
ラン器中にセツトし、1時間後、3時間後、5
時間後、7時間後の水分量を測定し、3回の平
均値を用いて水分*2)保持率を算出した。尚、
水分量の測定は平沼産業製、微量水分計AQ−
3を使用した。その結果を表−2に示す。
*2)
水分保持率=経時後の試料中の水分量/経時後の試料中
の水分量×100[Table] 2 Moisture retention ability evaluation Γ Samples: (a) beef tallow extracted lipid mixture according to the present invention obtained in Production Example 1, and as comparison products (b) sphingomyelin (phospholipid), (c) cerebroside ( glycolipids), (d) cholesterol, (f) a mixture of equal amounts of sphingomyelin and cerebroside, (f) a mixture of equal amounts of sphingomyelin and cholesterol,
(g) A mixture of equal amounts of cerebroside and cholesterol was used. Γ Method: Add 4 times the weight of water to each of the samples (a) to (g) to swell them (80% water content), weigh 1 g each into a 3 cm diameter shear dish, This was set in a furan oven at a temperature of 5°C and a RH of 45%, and after 1 hour, 3 hours, and 5%
After 7 hours, the water content was measured, and the water retention rate *2) was calculated using the average value of the three measurements. still,
Moisture content can be measured using a trace moisture meter AQ- manufactured by Hiranuma Sangyo.
3 was used. The results are shown in Table-2. *2) Moisture retention rate = Moisture content in the sample after aging / Moisture content in the sample after aging × 100
【表】
表−1及び表−2の結果が示すように、本発明
に係る脂質混合物は、吸湿性が適度であり、反面
水分保持能が高く保水性に優れていることが実証
された。斯様に、本発明に係る脂質混合物に含ま
れる個々の成分乃至は2種の混合物にあつても然
程水分保持能が高くない状況にあつて、本発明に
係る脂質混合物が優れ水分保持能を有している点
については、正に前記した如く、本発明に係る脂
質混合物が水を採り込んだ状態での液晶形成能が
高く、よつて保水性を高めている証左といえる。
更に、本発明に係る脂質混合物を配合した本発
明の皮膚外用剤を評価するために実施した検定結
果と使用テストの結果を以下に示す。
3 水分保持機能評価
Γ 試料:後記実施例1に示した本発明の軟膏
と、比較品として後記実施例1の軟膏における
牛脳抽出脂質混合物の替りに、ソルビタンモノ
ステアレートを配合したた軟膏(A)、レシチンを
配合した(B)及びスフインゴミエリンとセレブロ
シドとの等量混合物を配合した軟膏(C)を用い
た。
Γ 方法:上記の試料をそれぞれ5gずつ、直径
3cmのシヤーレに秤り取り、これを35℃、
RH45%のフラン器中にセツトし、1時間後、
3時間後、5時間後、7時間後の試料重量を測
定して、軟膏系よりの水分蒸散率*3)を算出し
た。その結果を表−3に示す。
*3)
水分蒸散率=[5(g)−経時後試料重量
(g)]/0.39(g)×100[Table] As shown by the results in Tables 1 and 2, it was demonstrated that the lipid mixture according to the present invention has moderate hygroscopicity, and on the other hand, has high water retention ability and excellent water retention. In this way, in situations where individual components or a mixture of two components contained in the lipid mixture according to the present invention do not have a particularly high water retention ability, the lipid mixture according to the present invention has an excellent water retention ability. As mentioned above, the fact that the lipid mixture according to the present invention has a high ability to form liquid crystals in a state in which water is incorporated can be said to be evidence that the water retention property is improved. Furthermore, the results of an assay and a use test conducted to evaluate the external skin preparation of the present invention containing the lipid mixture of the present invention are shown below. 3 Moisture retention function evaluation Γ Samples: The ointment of the present invention shown in Example 1 below, and an ointment containing sorbitan monostearate instead of the bovine brain extract lipid mixture in the ointment of Example 1 below as a comparative product ( A), an ointment containing lecithin (B), and an ointment containing a mixture of equal amounts of sphingomyelin and cerebroside (C) were used. Γ Method: Weigh 5g of each of the above samples into a 3cm diameter shear dish, and heat it at 35℃.
Set it in a furan container with RH45%, and after 1 hour,
The weight of the sample was measured after 3 hours, 5 hours, and 7 hours, and the water transpiration rate *3) from the ointment system was calculated. The results are shown in Table-3. *3) Moisture evaporation rate = [5 (g) - sample weight after aging (g)] / 0.39 (g) x 100
【表】
4 閉塞性評価
Γ 試料:水分保持能評価に用いたものと同一の
本発明品と比較品(A),(B)及び(C)を用いた。
Γ 方法:直径35mmの深形シヤーレに水10gを入
れてロ紙(東洋ロ紙No.5C)で蓋をし、このロ
紙上に上記の試料をそれぞれ一定量(0.2g)
均一に塗布して、35℃下15時間放置後の水残存
量(g)を測定し、閉塞率*4)を算出した。そ
の結果を表−4に示す。
*4)
閉塞率=
(1−試料塗布時の減水量(g)/試料無塗布時の
減水量(g))×100[Table] 4 Obstruction Evaluation Γ Samples: The same inventive product and comparative products (A), (B), and (C) as used in the water retention capacity evaluation were used. Γ Method: Pour 10 g of water into a deep-shaped petri dish with a diameter of 35 mm, cover it with RO paper (Toyo RO paper No. 5C), and place a certain amount (0.2 g) of each of the above samples on the RO paper.
After it was applied uniformly and left for 15 hours at 35°C, the remaining amount of water (g) was measured and the blockage rate *4) was calculated. The results are shown in Table 4. *4) Blockage rate = (1 - water loss when applying sample (g) / water loss when no sample is applied (g)) x 100
【表】
5 角質層水分量評価及び使用テスト評価
Γ 試料:水分保持能評価に用いたものと同一の
本発明品と比較品(A),(B)及び(C)を用いた。
Γ 方法:女性パネラー5名に、上記の試料をそ
れぞれ前腕内側部に塗布してもらい、その時の
使用感(官能評価)及び角質層中の水分量の経
時変化を*5)インピーダンスメーター法により
測定し、平均値(n=5)を図表化した。(第
1図参照)また、官能評価の結果を表−5に示
す。
*5)
インピーダンスメータ法:皮膚角質層中の薄電
性(μ)を測定することにより、角質層中の
水分量を測定する。測定機器;I.B.S社インピ
ーダンスメーターモデルIB−355、測定条件;
20℃、RH=50%。[Table] 5 Evaluation of stratum corneum moisture content and use test evaluation Γ Samples: The same inventive product and comparative products (A), (B), and (C) used in the evaluation of water retention ability were used. Γ Method: Have 5 female panelists apply each of the above samples on the inner side of their forearms, and measure the feeling of use (sensory evaluation) and changes in water content in the stratum corneum over time *5) using the impedance meter method. The average values (n=5) were plotted. (See Figure 1) The results of the sensory evaluation are shown in Table 5. *5) Impedance meter method: Measures the amount of water in the stratum corneum by measuring the thin conductivity (μ) in the stratum corneum. Measuring equipment: IBS impedance meter model IB-355, measurement conditions;
20℃, RH=50%.
【表】
表−3〜表−5及び第1図の結果が示すよう
に、本発明の皮膚外用剤は、水分蒸散量が低くし
たがつて保水性があり、閉塞性が良く角質層水分
量を長時間維持し、且つ使用感の上からもべたつ
き等がない優れたものになつていることが明らか
となつた。
以下に実施例を示す。尚、配合割合は重量%で
ある。
実施例 1
軟 膏
流動パラフイン 65
ワセリン 5
P.O.E(20)ソルビタンモノステアレート 6
ミツロウ 3
牛脳抽出脂質混合物 3
グリセリン 10
防腐剤 0.2
水 7.8
実施例 2
クリーム
ステアリン酸 2
ステアリルアルコール 1
還元ラノリン 1.8
スクワラン 10
牛脳抽出脂質混合物 1.2
オクチルドデカノール 6
P.O.E(25)セチルエーテル 3
グリセリルモノステアレート 2
香 料 0.3
防腐剤 0.2
グリセリン 5
水 67.5
実施例 3
乳 液
P.O.E付加(50)硬化ヒマシ油 1
ヤシ油脂肪酸モノグリセライド 1
豚脳抽出脂質混合物 0.5
オレイン酸トリグリセライド 7.5
グリセリン 2.5
香 料 0.2
防腐剤 0.2
水 87.1
実施例 4
ローシヨン
P.O.E付加(60)硬化ヒマシ油 0.5
牛脳抽出脂質混合物 0.2
グリセリン 5
クエン酸 0.1
クエン酸ソーダ 0.2
エタノール 10
香 料 0.1
防腐剤 0.1
水 83.8[Table] As shown by the results in Tables 3 to 5 and Figure 1, the skin external preparation of the present invention has low water evaporation and therefore has water retention properties, and has good occlusive properties and has good stratum corneum water content. It has become clear that the product maintains its properties for a long time and has an excellent feeling of use without any stickiness or the like. Examples are shown below. Incidentally, the blending ratio is in weight %. Example 1 Ointment liquid paraffin 65 Vaseline 5 POE(20) sorbitan monostearate 6 Beeswax 3 Bovine brain extract lipid mixture 3 Glycerin 10 Preservative 0.2 Water 7.8 Example 2 Cream stearic acid 2 Stearyl alcohol 1 Reduced lanolin 1.8 Squalane 10 Bovine Brain extract lipid mixture 1.2 Octyldodecanol 6 POE (25) Cetyl ether 3 Glyceryl monostearate 2 Flavor 0.3 Preservative 0.2 Glycerin 5 Water 67.5 Example 3 Emulsion POE addition (50) Hydrogenated castor oil 1 Coconut oil fatty acid monoglyceride 1 Pig brain extract lipid mixture 0.5 Oleic acid triglyceride 7.5 Glycerin 2.5 Flavor 0.2 Preservative 0.2 Water 87.1 Example 4 Lotion POE addition (60) hydrogenated castor oil 0.5 Bovine brain extract lipid mixture 0.2 Glycerin 5 Citric acid 0.1 Sodium citrate 0.2 Ethanol 10 Fragrance 0.1 Preservative 0.1 Water 83.8
第1図は、インピーダンスメーター法による一
定時間(30分、60分、90分、120分、180分)経過
後の、皮膚角質層中の導電性(μ)の結果を示
したものであり、Xは本発明品、Yは比較品(A)、
Zは比較品(B)、Wは比較品(C)である。
Figure 1 shows the results of conductivity (μ) in the stratum corneum of the skin after a certain period of time (30 minutes, 60 minutes, 90 minutes, 120 minutes, 180 minutes) using the impedance meter method. X is the invention product, Y is the comparative product (A),
Z is a comparative product (B), and W is a comparative product (C).
1 低沸点溶剤30〜70重量部および液化ガス70〜
30重量部を合計量が100重量部になるようにエア
ゾール容器に充填した、25℃における圧力が2.0
〜5.0Kg/cm2Gであるエアゾール容器入養毛剤で
あつて、前記エアゾール容器が、頭皮におしつけ
たとき、頭皮を刺激するとともにバルブを作動さ
せて養毛剤を噴射させるボタンを有する噴射口
で、養毛剤を直接頭皮に付与しうる噴射口を有す
るエアゾール容器であることを特徴とするエアゾ
ール容器入養毛剤。
2 低沸点溶剤および液化ガスの合計量100重量
部に対して、養毛基剤0.01〜15重量部が含有され
ている特許請求の範囲第1項記載のエアゾール容
器入養毛剤。
3 前記低沸点溶剤がトリクロロモノフルオロメ
タンおよび(または)ジクロロテトラフルオロエ
タンを主成分とする低沸点溶剤である特許請求の
範囲第1項記載のエアゾール容器入養毛剤。
4 前記液化ガスをジクロロジフルオロメタンを
主成分とする液化ガスである特許請求の範囲第1
項記載のエアゾール容器入養毛剤。
1 30 to 70 parts by weight of low boiling point solvent and 70 to 70 parts by weight of liquefied gas
30 parts by weight was filled into an aerosol container for a total amount of 100 parts by weight, and the pressure at 25°C was 2.0.
A hair tonic in an aerosol container with a weight of ~5.0 Kg/cm 2 G, the aerosol container having a nozzle that stimulates the scalp when applied to the scalp and has a button that activates a valve to spray the hair tonic. 1. A hair growth agent contained in an aerosol container, characterized in that the container is an aerosol container having an injection port that can directly apply the hair to the scalp. 2. The hair nourishing agent in an aerosol container according to claim 1, which contains 0.01 to 15 parts by weight of a hair nourishing base per 100 parts by weight of the total amount of the low boiling point solvent and liquefied gas. 3. The hair growth agent in an aerosol container according to claim 1, wherein the low boiling point solvent is a low boiling point solvent containing trichloromonofluoromethane and/or dichlorotetrafluoroethane as a main component. 4. Claim 1, wherein the liquefied gas is a liquefied gas whose main component is dichlorodifluoromethane.
Hair nourishing agent in an aerosol container as described in Section 1.
Claims (1)
の割合では混和しない極性の低い有機溶媒で、あ
るいは該有機溶媒と低級アルキルアルコールとの
混合物で抽出して得られたリン脂質、糖脂質、コ
レステロールを主成分とする脂質混合物を有効成
分として水を含有する外用基剤中に配合すること
を特徴とする皮膚外用剤。 2 皮膚外用剤が化粧料である特許請求の範囲第
1項記載の皮膚外用剤。[Claims] 1. A brain tissue obtained by extracting mammalian brain tissue with a low polar organic solvent that is immiscible with water in any proportion, or with a mixture of the organic solvent and lower alkyl alcohol. 1. A skin external preparation, characterized in that a lipid mixture containing phospholipids, glycolipids, and cholesterol as main components is blended into an external base containing water as an active ingredient. 2. The skin external preparation according to claim 1, wherein the skin external preparation is a cosmetic.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59019249A JPS60163806A (en) | 1984-02-03 | 1984-02-03 | Skin pharmaceutical for external use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59019249A JPS60163806A (en) | 1984-02-03 | 1984-02-03 | Skin pharmaceutical for external use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60163806A JPS60163806A (en) | 1985-08-26 |
| JPH0457641B2 true JPH0457641B2 (en) | 1992-09-14 |
Family
ID=11994137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59019249A Granted JPS60163806A (en) | 1984-02-03 | 1984-02-03 | Skin pharmaceutical for external use |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60163806A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60183032A (en) * | 1984-03-02 | 1985-09-18 | Shiseido Co Ltd | Emulsified composition |
| JPH0657651B2 (en) * | 1985-05-15 | 1994-08-03 | サンスタ−株式会社 | Cosmetic composition |
| JPH0768103B2 (en) * | 1985-06-17 | 1995-07-26 | ポーラ化成工業株式会社 | External skin preparation |
| JPS6323808A (en) * | 1986-07-16 | 1988-02-01 | Noebia:Kk | Skin drug for external use |
| JPS6416708A (en) * | 1987-07-08 | 1989-01-20 | Ichimaru Pharcos Inc | Composition for extracting sphingolipid and method for extraction thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH399655A (en) * | 1961-07-07 | 1965-09-30 | Hoffmann La Roche | Skin care products |
-
1984
- 1984-02-03 JP JP59019249A patent/JPS60163806A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60163806A (en) | 1985-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW457094B (en) | Topical composition for enhancing lipid barrier synthesis | |
| GB2079179A (en) | Cosmetic Composition Based On an Aqueous Dispersion of Small Lipid Spheres | |
| JPH0375523B2 (en) | ||
| EP1043016B1 (en) | A plant extract based on glycerides,phospholipids and phytosphingolipids, a method for the preparation of this extract and a cosmetic composition containing the same | |
| JPH0566922B2 (en) | ||
| JPS624362B2 (en) | ||
| KR101155807B1 (en) | Cosmetic composition for moisturizing and firming the skin | |
| KR101605324B1 (en) | Cosmetic composition for moisturizing skin which alleviates itchiness and dryness by removing keratin and increasing moisture | |
| JPH0611686B2 (en) | Cosmetics | |
| JPH05124930A (en) | Cosmetics | |
| JPS61289013A (en) | Skin external agent | |
| JPH0457641B2 (en) | ||
| WO2022003056A1 (en) | Extract of hibiscus sabdariffa and use thereof for improving the barrier function and promoting the moisturization and desquamation of the skin | |
| KR20230057368A (en) | Silybum marianum (L.) Gaerten for strengthening the barrier function of the skin. oil | |
| JP3991164B2 (en) | Cosmetic composition comprising jujube extract and walnut extract | |
| JP2008169196A (en) | Skin preparation | |
| JP2004175688A (en) | Whitening agents and cosmetics | |
| JP2009221173A (en) | Keratin status ameliorator | |
| JP2673887B2 (en) | Cosmetics | |
| JP2004269433A (en) | Cosmetic composition | |
| JP3481775B2 (en) | Microemulsions and cosmetics containing them | |
| JPS61289018A (en) | Skin external agent | |
| JP2000143527A (en) | Hyaluronic acid production promoter and skin preparation for external use containing the same | |
| KR102306745B1 (en) | Moisturizing composition comprising ardisia crenata extract and aneilema keisak extract as an effective ingredient | |
| JP2001508789A (en) | Cosmetic or dermatological products compatible with skin ecology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |